Samsung NeuroLogica CyberKnife imaging pact lifts Accuray
Sunday Samsung NeuroLogica CyberKnife imaging pact lifts Accuray 52% pre-market
- Accuray announced Sunday agreements with Samsung NeuroLogica to pursue volumetric imaging for CyberKnife.
- PR Newswire release timed with ASTRO 2026 meeting in Boston, where firms highlight the work.
- No commercial product, deal terms or timeline given; effort is phased and regulatory-dependent.
- Royal Marsden is the first clinical site evaluating the imaging-plus-radiosurgery concept.
- Friday close was $0.22; weekend news produced the early Monday pre-market jump to $0.33.
- 52% move far exceeds the stock’s 6-7% average daily range as a $39 million micro-cap.
- X posts mainly recirculated the press release and flagged the pre-market percentage gain.
- No fresh 8-K, offering or other filing since Friday; reverse-split vote is set for October 6.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.